Clinical Scorecard: Creation and internal assessment of a predictive nomogram for adverse pregnancy outcomes in women experiencing early-onset preeclampsia

At a Glance

Key Highlights

• Developed a nomogram for predicting adverse pregnancy outcomes in EOPE.
• Identified seven independent predictors: gestational age, systolic blood pressure, urine protein score, platelet count, AST level, fetal growth restriction, and HELLP syndrome.
• Model demonstrated good discrimination with an AUC of 0.859.
• Calibration curves indicated acceptable agreement between predicted and observed risks.
• Decision curve analysis suggested potential clinical net benefit.

Guideline-Based Recommendations

Diagnosis

• Use clinical predictors measured at admission or within the first 24 hours.

Management

• Implement risk stratification for patients diagnosed with EOPE.

Monitoring & Follow-up

• Monitor identified predictors to assess risk of adverse outcomes.

Risks

• Higher risks of maternal complications, fetal growth restriction, preterm delivery, and perinatal death.

Patient & Prescribing Data

Women diagnosed with early-onset preeclampsia admitted to a tertiary hospital.

Low-dose aspirin may reduce the risk of preeclampsia in high-risk pregnancies.

Clinical Best Practices

• Utilize the nomogram for admission-based risk stratification.
• Conduct independent multicenter validation before clinical implementation.

Related Resources & Content

• Study on predictive nomogram for EOPE